Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice

Lisa D. Coles, Insong J. Lee, Hazem E. Hassan, Natalie D. Eddington

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Efflux transporters such as P-glycoprotein (P-gp) play a critical role in the maternal-to-fetal and blood-to-brain transfer of many drugs. Using a mouse model, the effects of gestational age on P-gp and MRP expression in the placenta and brain were evaluated. P-gp protein levels in the placenta and brain were greater at mid-gestation (gd 13) than late-gestation (gd 18). Likewise, brain MRP1 levels were greater at mid-gestation, whereas, placental levels were greater at late-gestation. To evaluate these effects on drug disposition, concentrations of [3H]saquinavir, [3H]methadone, [ 3H]buprenorphine, and the paracellular marker, [14C] mannitol were measured in plasma, brain, placenta, and fetal samples after i.v. administrations to nonpregnant and pregnant mice. Following i.v. administration, [3H]saquinavir placenta-to-plasma and fetal-to-plasma ratios were significantly greater in lategestation mice versus mid-gestation. Furthermore, late-gestation mice experienced significant increases in the [ 3H]saquinavir and [3H]methadone brain-to-plasma ratios 60 min after dosing relative to mid-gestation (p<0.05). No significant differences were observed in these tissue-to-plasma ratios for buprenorphine or mannitol. Repeated dosing (three doses, once daily) decreased the differential uptake of [3H]saquinavir in brain but potentiated it in the fetus. These results suggest that differential expression of P-gp and possibly MRP1 contributes to the gestational-induced changes in brain and fetal uptake of saquinavir.

Original languageEnglish (US)
Pages (from-to)2832-2846
Number of pages15
JournalJournal of Pharmaceutical Sciences
Volume98
Issue number8
DOIs
StatePublished - Jan 1 2009

Fingerprint

Saquinavir
Buprenorphine
Methadone
Placenta
Fetus
Mothers
Pregnancy
Brain
P-Glycoprotein
Mannitol
Fetal Blood
Pharmaceutical Preparations
Gestational Age

Keywords

  • ABC transporters
  • Blood-brain barrier
  • Distribution
  • MRP
  • P-glycoprotein
  • Placenta
  • Pregnancy

Cite this

Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. / Coles, Lisa D.; Lee, Insong J.; Hassan, Hazem E.; Eddington, Natalie D.

In: Journal of Pharmaceutical Sciences, Vol. 98, No. 8, 01.01.2009, p. 2832-2846.

Research output: Contribution to journalArticle

@article{b0dd0cc6bc734943b2a3db659af128e0,
title = "Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice",
abstract = "Efflux transporters such as P-glycoprotein (P-gp) play a critical role in the maternal-to-fetal and blood-to-brain transfer of many drugs. Using a mouse model, the effects of gestational age on P-gp and MRP expression in the placenta and brain were evaluated. P-gp protein levels in the placenta and brain were greater at mid-gestation (gd 13) than late-gestation (gd 18). Likewise, brain MRP1 levels were greater at mid-gestation, whereas, placental levels were greater at late-gestation. To evaluate these effects on drug disposition, concentrations of [3H]saquinavir, [3H]methadone, [ 3H]buprenorphine, and the paracellular marker, [14C] mannitol were measured in plasma, brain, placenta, and fetal samples after i.v. administrations to nonpregnant and pregnant mice. Following i.v. administration, [3H]saquinavir placenta-to-plasma and fetal-to-plasma ratios were significantly greater in lategestation mice versus mid-gestation. Furthermore, late-gestation mice experienced significant increases in the [ 3H]saquinavir and [3H]methadone brain-to-plasma ratios 60 min after dosing relative to mid-gestation (p<0.05). No significant differences were observed in these tissue-to-plasma ratios for buprenorphine or mannitol. Repeated dosing (three doses, once daily) decreased the differential uptake of [3H]saquinavir in brain but potentiated it in the fetus. These results suggest that differential expression of P-gp and possibly MRP1 contributes to the gestational-induced changes in brain and fetal uptake of saquinavir.",
keywords = "ABC transporters, Blood-brain barrier, Distribution, MRP, P-glycoprotein, Placenta, Pregnancy",
author = "Coles, {Lisa D.} and Lee, {Insong J.} and Hassan, {Hazem E.} and Eddington, {Natalie D.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1002/jps.21644",
language = "English (US)",
volume = "98",
pages = "2832--2846",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice

AU - Coles, Lisa D.

AU - Lee, Insong J.

AU - Hassan, Hazem E.

AU - Eddington, Natalie D.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Efflux transporters such as P-glycoprotein (P-gp) play a critical role in the maternal-to-fetal and blood-to-brain transfer of many drugs. Using a mouse model, the effects of gestational age on P-gp and MRP expression in the placenta and brain were evaluated. P-gp protein levels in the placenta and brain were greater at mid-gestation (gd 13) than late-gestation (gd 18). Likewise, brain MRP1 levels were greater at mid-gestation, whereas, placental levels were greater at late-gestation. To evaluate these effects on drug disposition, concentrations of [3H]saquinavir, [3H]methadone, [ 3H]buprenorphine, and the paracellular marker, [14C] mannitol were measured in plasma, brain, placenta, and fetal samples after i.v. administrations to nonpregnant and pregnant mice. Following i.v. administration, [3H]saquinavir placenta-to-plasma and fetal-to-plasma ratios were significantly greater in lategestation mice versus mid-gestation. Furthermore, late-gestation mice experienced significant increases in the [ 3H]saquinavir and [3H]methadone brain-to-plasma ratios 60 min after dosing relative to mid-gestation (p<0.05). No significant differences were observed in these tissue-to-plasma ratios for buprenorphine or mannitol. Repeated dosing (three doses, once daily) decreased the differential uptake of [3H]saquinavir in brain but potentiated it in the fetus. These results suggest that differential expression of P-gp and possibly MRP1 contributes to the gestational-induced changes in brain and fetal uptake of saquinavir.

AB - Efflux transporters such as P-glycoprotein (P-gp) play a critical role in the maternal-to-fetal and blood-to-brain transfer of many drugs. Using a mouse model, the effects of gestational age on P-gp and MRP expression in the placenta and brain were evaluated. P-gp protein levels in the placenta and brain were greater at mid-gestation (gd 13) than late-gestation (gd 18). Likewise, brain MRP1 levels were greater at mid-gestation, whereas, placental levels were greater at late-gestation. To evaluate these effects on drug disposition, concentrations of [3H]saquinavir, [3H]methadone, [ 3H]buprenorphine, and the paracellular marker, [14C] mannitol were measured in plasma, brain, placenta, and fetal samples after i.v. administrations to nonpregnant and pregnant mice. Following i.v. administration, [3H]saquinavir placenta-to-plasma and fetal-to-plasma ratios were significantly greater in lategestation mice versus mid-gestation. Furthermore, late-gestation mice experienced significant increases in the [ 3H]saquinavir and [3H]methadone brain-to-plasma ratios 60 min after dosing relative to mid-gestation (p<0.05). No significant differences were observed in these tissue-to-plasma ratios for buprenorphine or mannitol. Repeated dosing (three doses, once daily) decreased the differential uptake of [3H]saquinavir in brain but potentiated it in the fetus. These results suggest that differential expression of P-gp and possibly MRP1 contributes to the gestational-induced changes in brain and fetal uptake of saquinavir.

KW - ABC transporters

KW - Blood-brain barrier

KW - Distribution

KW - MRP

KW - P-glycoprotein

KW - Placenta

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=68249104087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249104087&partnerID=8YFLogxK

U2 - 10.1002/jps.21644

DO - 10.1002/jps.21644

M3 - Article

C2 - 19116954

AN - SCOPUS:68249104087

VL - 98

SP - 2832

EP - 2846

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 8

ER -